ERS International Congress, Milan 2017

---

Respiratory infections in critically ill and immuno-depressed patientes

Thematic Poster
Chairs: M. Ferrer Monreal (Barcelona, Spain), A. Torres (Barcelona, Spain), I. Martin-Loeches (Dublin 8, Ireland), M. Restrepo (San Antonio, United States of America)

Risk factors and outcomes of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa: a clinical case-control study D. Feng (Guang zhou, China)
Pneumonia caused by extensive drug-resistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortality Z. Zhao (Beijing, China)
Risk factors for drug-resistant pathogens in patients with hospital-acquired and ventilator-associated pneumonia M. Sano (Nagoya, Japan)
Detection of alpha-hemolysin in Staphylococcus aureus derived respiratory strains: correlation with microbiological and clinical variables A. Lacoma De La Torre (Badalona (Barcelona), Spain)
Predictors of mortality in VAP following cardiac surgery – adult and pediatric K. Supraja (CHENNAI (TAMIL NADU), India)
The impact of septic shock on intensive care unit-acquired pneumonia survival is not homogenous O. Tavares Ranzani (Sao Paulo/Sp, Brazil)
Community-Acquired Pneumococcal Pneumonia in Virologically Suppressed HIV-Infected Adult Patients: A Matched Case-Control Study C. Cilloniz Campos (Barcelona, Spain)
Sepsis related to pneumonia after renal transplantation V. Pencheva (Sofia, Bulgaria)
Clinical Utility of Different Methods In Diagnosis Of Pulmonary Cryptococosis In Patients Without HIV Infection Y. Li (wenzhou, China)
Cell-mediated immunity in patients with Pneumocystis jirovecii pneumonia G. Parrott (Okinawa City, Japan)
Prevalence and risk factors for pulmonary aspergillosis infection in thoracic oncology: a 5 years retrospective study J. Cuilleron (LYON, France)
Clinicopathologic features of pulmonary Cryptococcus Y. Choi (Gwangju, Republic of Korea)
Invasive pulmonary aspergillosis in immunocompetent patients acquired during renovation in a chest institute K. Agarwal (DELHI (NEW DELHI), India)
Pneumocystis jirovecii pneumonia, study of 26 cases S. Calero Pardo (Madrid, Spain)
Lung Cancer and bronchial infection P. Bruno (ROMA, RM, Italy)
Mortality and prognostic factors of necrotizing community acquired pneumonia (NCAP) in a general hospital M. Solis Aramayo (Ciudad Autónoma Buenos Aires, Argentina)
Microorganisms resistant to conventional antimicrobial treatment in acute exacerbation of COPD C. Estirado (BARCELONA, Spain)
Neutrophil CD64 versus Neutrophil/Lymphocyte ratio (NLR) as markers predicting in-hospital outcome in acute exacerbation of COPD A. Mohamed-Hussein (Assiut, Egypt)
The association between Chlamydia pneumoniae chronic infection and inflammation in COPD patients. M. Paplinska-Goryca (Warszawa, Poland)